Location of Coronary-artery Lesion Not Tied to Stenting Outcome Location of Coronary-artery Lesion Not Tied to Stenting Outcome
The outcomes of percutaneous coronary intervention (PCI) with new-generation drug-eluting stents (DES) in patients with proximal left anterior descending (P-LAD) coronary-artery lesions appear similar to those seen in patients with lesions in other segments, according to data from three clinical trials.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 25, 2020 Category: Consumer Health News Tags: Medscape Today News Source Type: news
CTO PCI Linked to Worse Outcomes in Patients With Prior CABG CTO PCI Linked to Worse Outcomes in Patients With Prior CABG
Observational data show less technical success and worse outcomes with angioplasty of chronic total occlusions after bypass surgery. Such procedures should be limited to expert centers, researchers say.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 24, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news
Philips Ramps Up Production of Critical Health Technology Products in Response to COVID-19 Pandemic
Philips is ramping up the production of hospital ventilators and plans to double production within the next eight weeks and achieve a four-fold increase by the third quarter of 2020. The company is mobilizing its global supplier network to step up support and production in this extraordinary situation. Philips has a global manufacturing footprint with final assembly sites in North America, Europe and Asia, and, equally important, a global network of certified materials and component suppliers. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - March 23, 2020 Category: Cardiology Source Type: news
Medtronic Has Ramped Up Ventilator Production
Medtronic, manufacturer of the Puritan Bennett line of ventilators, reports that they have already increased their production by 40% and are "on track" to achieve twice their normal output. Manufactured in Galway, Ireland, Medtronic's workforce numbers 250. The company is doubling that, bringing in new people and transferring staff from other Medtronic sites, and reconfiguring its plant to operate 24/7. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - March 19, 2020 Category: Cardiology Source Type: news
Dual Therapy Linked to Lower Bleeding Risk in A-Fib After PCI
MONDAY, March 16, 2020 -- For patients with atrial fibrillation (AF) after percutaneous coronary intervention (PCI), dual therapy is associated with a reduced risk for bleeding compared with triple therapy, according to research published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 16, 2020 Category: Pharmaceuticals Source Type: news
Cracking (the Code of) CAC to Win the Last Battle of PCI Cracking (the Code of) CAC to Win the Last Battle of PCI
A new study elucidates the underlying mechanism for an increased risk when treating calcified lesions during percutaneous coronary intervention with newer generation drug-eluting stents.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 6, 2020 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news
2003 to 2016 Saw Changes in Characteristics of PCI, CABG Patients
MONDAY, March 2, 2020 -- Between 2003 and 2016, there were decreases in in-hospital mortality after coronary artery bypass grafting (CABG) but not after percutaneous coronary intervention (PCI), according to a study published online Feb. 14 in JAMA... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - March 2, 2020 Category: Pharmaceuticals Source Type: news
Abbott recalls 2 coronary angioplasty catheters
Pharmaceutical and healthcare company Abbott Laboratories has issued a voluntary...Read more on AuntMinnie.comRelated Reading:
FDA clears Abbott's ICD for use with MRI
Abbott, CARO reach 10-year milestone
Abbott to bring Xience V to China
Abbott takes Xience Prime stent overseas
Medtronic, Abbott bury patent-dispute hatchet (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 25, 2020 Category: Radiology Source Type: news
Philips Seeks Better Understanding of PCI Outcomes Through New Trial
Philips is continuing its investment into percutaneous coronary intervention (PCI) procedures through a new study. The company announced the (Distal Evaluation of Functional performance with Intravascular sensors to assess the Narrowing Effect: Guided Physiologic Stenting) (DEFINE GPS) global multicenter study, which has a goal to assess outcomes of PCI procedures guided by integrated iFR and interventional X-ray images. The announcement of the study comes on the heels of Philips making a bid to shed its appliances unit so it can focus on healthcare.Â
The primary endpoint is target vessel failure (a composite o...
Source: MDDI - February 21, 2020 Category: Medical Devices Authors: Omar Ford Tags: Business Imaging Source Type: news
Polymer-Based Stents Noninferior for Patients With High Bleeding Risk
THURSDAY, Feb. 20, 2020 -- Polymer-based zotarolimus-eluting stents are noninferior to polymer-free drug-coated stents among patients at high bleeding risk undergoing percutaneous coronary intervention (PCI), according to a study published online... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 20, 2020 Category: Pharmaceuticals Source Type: news
Medtronic Begins New Pilot Study as Part of SPYRAL HTN Clinical Program for Renal Denervation in Hypertension Patients
Medtronic plc (NYSE:MDT) today announced it will begin enrollment in a pilot study evaluating the safety and efficacy of the Symplicity ™ Spyral renal denervation (RDN) system using a targeted procedural approach with a reduced number of radio frequency (RF) ablations. Set to enroll 50 patients at up to 15 sites in the U.S. and Europe, the single-arm study is designed to focus on ablating the distal main renal artery and primary b ranches to lower blood pressure utilizing a simplified procedural approach. (Source: News from Angioplasty.Org)
Source: News from Angioplasty.Org - February 4, 2020 Category: Cardiology Source Type: news
Biodegradable Coronary Stents Better Than Durable Stents in Registry Study Biodegradable Coronary Stents Better Than Durable Stents in Registry Study
Patients with acute myocardial infarction (MI) who underwent percutaneous coronary intervention (PCI) had better outcomes with biodegradable polymer drug-eluting stents (BP-DES) than with second-generation durable polymer drug-eluting stents (DP-DES), a South Korean registry study found.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 17, 2020 Category: Consumer Health News Tags: Cardiology News Source Type: news
U.S. Prices For Healthcare Services Far Outpace Peer Nations
The fact that angioplasties and hospital stays are much more expensive in the U.S. is not reflective of angioplasties or hospital stays being better in the U.S. Hospitals in the U.S. charge $32,000 for an angioplasty because they can in a market with non-competitive features. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - January 15, 2020 Category: Pharmaceuticals Authors: Joshua Cohen, Contributor Source Type: news
FDA offers guidance on angioplasty and specialty catheters
The U.S. Food and Drug Administration (FDA) has issued a draft guidance for...Read more on AuntMinnie.comRelated Reading:
FDA offers guidance on coated devices
Cinematic rendering offers clinical utility in MSK CT
Coronary CTA beats stress test for changing lifestyles
Medtronic launches new endoscopic catheter
r4 Vascular gets FDA clearance for PTA balloon (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 10, 2020 Category: Radiology Source Type: news
Today, the @US_FDA issued the draft guidance: Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters – Premarket Notification (510(k)) Submissions.pic.twitter.com/UcPPibuz5y
Today, the @US_FDA issued the draft guidance: Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters – Premarket Notification (510(k)) Submissions. pic.twitter.com/UcPPibuz5y (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - January 10, 2020 Category: Medical Devices Authors: ( at FDADeviceInfo) Source Type: news
